Kelsey Duncan, MD
Neurology · Cleveland, OHNPI 1679004618
Payments from drug & device makers
What this record shows
14 manufacturers reported payments, led by Penumbra, Inc. at 55.2% of the total. 2025 is the largest year on record at $1,606, more than ten times the $92 reported in 2019.
Across 25 payments — averaging $89.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Penumbra, Inc.$1K
- Stryker$191
- Medtronic$174
- Contego Medical, Inc$122
- AbbVie$113
- Microvention, Inc.$101
- plus $299 from 8 others
What the payments were for
- Travel & lodging$1,22655%
- Food & beverage$1,00645%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Penumbra, Inc. | 5 | $1,232 |
| Stryker | 2 | $191 |
| Medtronic | 4 | $174 |
| Contego Medical, Inc | 1 | $122 |
| AbbVie | 1 | $113 |
| Microvention, Inc. | 1 | $101 |
| Acorda Therapeutics, Inc | 1 | $92 |
| AstraZeneca | 3 | $62 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $41 |
| Merz Pharmaceuticals, LLC | 1 | $26 |
| Lundbeck LLC | 1 | $22 |
| Neurelis, Inc. | 1 | $21 |
| Teva Pharmaceuticals USA, Inc. | 1 | $18 |
| Bristol Myers Squibb | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Penumbra System$1,087
- STENT$201
- TARGET$168
- Pipeline$118
- QULIPTA$113
- UBRELVY$113
- WEB Aneurysm Embolization System$101
How this compares
$2,231 in reported general payments places this provider in the 60th percentile of 702 neurology providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other neurology in Cleveland
- Imad NajmCleveland$373K
- Hesham AbboudCleveland$363K
- Robert BermelCleveland$302K
- Eric BaronCleveland$297K
- Robert FoxCleveland$296K
- Aarushi SunejaCleveland$269K
- Mary WillisCleveland$254K
- Benjamin WalterCleveland$210K
- Aasef ShaikhCleveland$186K
- Maryann MaysCleveland$173K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.